Oxford Vaccine

Purchase deal with firms only after Covid-19 vaccines prove effective: Centre

At present, vaccine candidates by Bharat Biotech, Serum Institute of India (Oxford University-AstraZeneca), and Zydus Cadila are under advanced stages of trials.

published on : 13th October 2020

Hoping to receive 50 crore doses of COVID-19 vaccine by July: Harsh Vardhan

The minister also said that the government is keeping an eye on immunity data with regard to Covid-19 disease while finalizing these plans, as reported by this newspaper earlier.

published on : 5th October 2020

Will Centre have Rs 80,000 crore for distribution of COVID-19 vaccine, asks Serum Institute CEO

The central health ministry official said that they have not received any official proposal from the institute regarding mass production, procurement, and distributions of the vaccine.

published on : 26th September 2020

Seven volunteers found ineligible for coronavirus vaccine trial due to 'medical reasons'

'All seven candidates who were selected on Monday have become ineligible due to various medical reasons, including antibody test coming positive for some,' said Dr Murlidhar Tambe.

published on : 22nd September 2020

Phase-III human clinical trial of Oxford COVID-19 vaccine begins in Pune

Under phase-II, trials had been conducted at the Bharti Vidyapeeth Medical College and also KEM Hospital in the city.

published on : 21st September 2020

Phase-III trial of Oxford vaccine to begin in Pune next week

Under phase-II, trials were conducted at Bharti Vidyapeeth Medical College and also KEM Hospital in the city.

published on : 20th September 2020

Covid-19 vaccine likely by early 2021 but will take time to reach all: Harsh Vardhan

Under PM Modi's guidance, an expert group is looking at it and we have advanced planning in place, the Union Health Minister said.

published on : 17th September 2020

Serum Institute of India gets DCGI nod to resume clinical trial of Oxford COVID-19 vaccine

SII has also been asked to submit to the DCGI's office details of medication used in accordance with the protocol for management of adverse events.

published on : 16th September 2020

Oxford vaccine trial stopped after volunteer developed neurological symptoms: AstraZeneca

The study participant in late-stage testing reported symptoms consistent with transverse myelitis, a rare inflammation of the spinal cord, said company spokesman Matthew Kent.

published on : 11th September 2020

Mysuru: Oxford vaccine trials halted in UK, but JSS institute's trials going fine

However, speaking to TNIE, B Suresh, Pro Chancellor of JSS AHER, said that so far, none among their 32 volunteers have reported any adverse reactions and all are doing fine.

published on : 10th September 2020

India will continue Oxford vaccine trial, says Serum Institute after illness in volunteer pauses trial abroad

Serum Institute of India, under whose aegis the vaccine is to be being tried on 1,600 participants across 17 centres, said that trials in India will continue, irrespective of the latest development.

published on : 9th September 2020

COVID-19 vaccine human trial: Vital signs of volunteers normal, says doctor

In all, 25 candidates will be given the vaccine in the next seven days.

published on : 27th August 2020

If everything goes well India would get COVID-19 vaccine by year-end: Harsh Vardhan

Three COVID-19 vaccine candidates, including two indigenous ones, are in different phases of development in India.

published on : 24th August 2020

Oxford Covid-19 vaccine to cost Rs 225 per dose in India: Serum Institute

The vaccine candidate is under advanced stages of clinical trials and likely to be available for public use in the first half of 2021.

published on : 7th August 2020

ICMR says two COVID-19 vaccines on phase 2 trial now but researchers differ

Principal Investigators involved in the vaccine trial said that it will take at least a month for the first phase of the trial to be completed.

published on : 4th August 2020
1 2 > 
IPL_2020